Recent findings on pertussis epidemiology in Turkey

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 5, 2008, Pages 335-341

  Dilli, D ^a   Bostanci, I ^a   Dallar, Y ^a   Buzgan, T ^b   Irmak, H ^b   Torunoglu M A ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PERTUSSIS; PRIORITY JOURNAL; TURKEY (REPUBLIC); VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GEOGRAPHY; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PERTUSSIS VACCINE; TURKEY; WHOOPING COUGH;

EID: 43049128818     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0442-x     Document Type: Article

References (37)

1. Versteegh FGA, Schellekens JFP, Fleer A, Roord JJ (2005) Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in management. Rev Med Microbiol 16:79-89
2. Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326-382
3. Cherry JD (2005) The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115:1422-1427
4. de Carvalho AP, Pereira EM (2006) Acellular pertussis vaccine for adolescents. J Pediatr (Rio J) 82(Suppl 3):S15-S24
5. Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage III Working Group (2001) Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 108:E81
6. Olin P, Gustafsson L, Barreto L, Hessel L, Mast TC, Rie AV, Bogaerts H, Storsaeter J (2003) Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine 21:2015-2021
7. Hadler SC, Cochi SL, Bilous J, Cutts FT (2003) Vaccination programs in developing countries. In: Plotkin SA, Orenstein WA (eds) Vaccines, 4th edn. Saunders, Philadelphia, pp 1407-1442
8. Halsey N, Galazka A (1985) The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ 63:1151-1169
9. Vatansever U, Cöplü N, Oner N, Sönmez C, Karasalihoǧlu S, Kurtoǧlu D, Esen B, Ekuklu G (2005) Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Med Wkly 135:531-536
10. Brooks DA, Clover R (2006) Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 19:603-611
11. American Academy of Pediatrics (2006) Summaries of infectious diseases: pertussis (whooping cough). In: Pickering LK (ed) Red book: report of the committee on infectious diseases, 27th edn. American Academy of Pediatrics, Elk Grove Village, pp 498-520
12. Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, Olander RM, Fivet-Groyne F, Baron S, Tischer A, Swidsinski S, Schellekens J, Reizenstein E (2003) European sero-epidemiology network: standardisation of the assay results for pertussis. Vaccine 8(22):112-120
13. Lynn F, Reed GF, Meade BD (1997) A comparison of enzyme immunoassays used to measure serum antibodies to components of Bordetella pertussis. Dev Biol Stand 89:197-204
14. Cutts FT (1998) Advances and challenges for the expanded programme on immunization. Br Med Bull 54:445-461
15. Ndumbe P (1996) Childhood vaccination: achievements and challenges. Afr Health 18:18-19
16. Aksakal FN, Cöplü N, Ceyhan MN, Sönmez C, Ozkan S, Esen B, Ilhan MN, Aygün R (2007) High incidence of pertussis among schoolchildren with prolonged cough in Turkey. Tohoku J Exp Med 211:353-358
17. Quinn HE, McIntyre PB (2007) Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Commun Dis Intell 31:205-215
18. Viney KA, McAnulty JM, Campbell-Lloyd S (2007) EPIREVIEW. Pertussis in New South Wales, 1993-2005: the impact of vaccination policy on pertussis epidemiology. N S W Public Health Bull 18:55-61
19. Cöplü N, Nar S, Efsun A, Kurtoǧlu D, Esen B (2007) A field survey carried out on the confirmation of a pertussis case in a village of Kirikkale Province, Turkey. Mikrobiyol Bul 41:175-183
20. Esen B, Cöplü N, Kurtoǧlu D, Gözalan A, Akin L (2007) Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants. J Clin Lab Anal 21:154-161
21. Ozcirpici B, Sahinöz S, Ozgür S, Bozkurt AI, Sahinöz T, Ceylan A, Ilcin E, Saka G, Acemoǧlu H, Palanci Y, Ak M, Akkafa F (2006) Vaccination coverage in the South-East Anatolian Project (SEAP) region and factors influencing low coverage. Public Health 120:145-154
22. Tan T, Trindade E, Skowronski D (2005) Epidemiology of pertussis. Pediatr Infect Dis J 24(Suppl 5):S10-S18
23. Centers for Disease Control and Prevention (2006) Final 2005 reports of notifiable diseases. MMWR Morb Mortal Wkly Rep 55:880-881
24. Wendelboe AM, Van Rie A, Salmaso S, Englund JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24:858-861
25. de Melker HE, Versteegh FGA, Schellekens JFP, Teunis PFM, Kretzschmar M (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53:106-113
26. Vera I, García-Comas L, Ordobas M, Gutierrez A, Sanz J, Barranco D (2007) Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005. Euro Surveill 12:E7-E8
27. al-Bargish KA (1999) Outbreak of pertussis in Basra, Iraq. East Mediterr Health J 5:540-548
28. Dominguez A, Vidal J, Plans P, Salleras L (2001) The seroepidemiology of B. pertussis infection in Catalonia, Spain. Epidemiol Infect 126:205-210
29. Schellekens J, von König CH, Gardner P (2005) Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 24(Suppl 5):S19-S24
30. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV (2003) Trends in pertussis among infants in the United States, 1980-1999. JAMA 290:2968-2975
31. Namachivayam P, Shimizu K, Butt W (2007) Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr Crit Care Med 8:207-211
32. Gregory DS (2006) Pertussis: a disease affecting all ages. Am Fam Physician 74:420-426
33. Plotkin S (2005) The global pertussis initiative: process overview. Pediatr Infect Dis J 24(Suppl 5):S7-S9
34. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S (2007) Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25:2634-2642
35. Wendelboe AM, Van Rie A (2006) Diagnosis of pertussis: a historical review and recent developments. Expert Rev Mol Diagn 6:857-864
36. Wirsing von König CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J (2005) Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J 24(Suppl 5):S87-S92
37. Mooi FR, de Greeff SC (2007) The case for maternal vaccination against pertussis. Lancet Infect Dis 7:614-624